fulgentgenetics.com - Rasio nilai perusahaan marang dodolan FLGT

Simbol resmi perusahaan Fulgent Genetics Inc (FLGT)

The enterprise value-to-revenue multiple demonstrates the dependence of Fulgent Genetics, Inc. (FLGT) on insurance reimbursement and oncology screening volumes, with the current level standing at 1223.79. The business relies on a high-performance staff of bioinformaticians and a modern DNA analysis IT platform. Currently, the revenue structure is balanced by subscription-based clinical genetics and pharmacological services, which has successfully neutralized the impact of pandemic testing.

fulgentgenetics.com (FLGT): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Rincian metrik keuangan lan pasar Fulgent Corp (FLGT)

Pambiji fundamental perusahaan:FLGT Fulgent Genetics, Inc.
Produk sing diprodhuksi Fulgent Genetics Inc

To objectively evaluate an issuer, a manager requires a tool that eliminates the impact of debt load on valuation. This indicator compares the total enterprise value to annual revenue, revealing actual market overvaluation or undervaluation. By analyzing the EV/Revenue ratio, an investor determines the strength of the pricing momentum regardless of financial obligations. For Fulgent Genetics, Inc. (FLGT), such transparency is critical. The humanitarian status of genetic research minimizes geopolitical risks, stabilizing the fundamental value of the company.

Analisis pesaing Fulgent Genetics, Inc.

A (Agilent) - Rasio nilai perusahaan marang pendapatan|DGX (Quest Diagnostics) - Nilai perusahaan marang pendapatan|Illumina Inc (ILMN) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan EXAS|Revvity, Inc. (RVTY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales BIO|NNNN (Anbio Biotechnology) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales SHC (Sotera Health)|Quidel Corporation (QDEL) - Multiplikator nilai perusahaan marang pendapatan|OPK - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Rasio nilai perusahaan marang pendapatan|LAB (Standard BioTools Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Cytek Biosciences Inc|Multiplikator nilai perusahaan marang pendapatan OraSure OSUR|Nilai perusahaan marang pendapatan XGN (Exagen Diagnostics)|Rasio total nilai perusahaan marang pendapatan MDxHealth Inc.|Rasio nilai perusahaan marang pendapatan Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Multiplikator nilai perusahaan marang pendapatan|Insight Molecular Diagnostics Inc - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan trinitybiotech.com|PRPH (ProPhase) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AIMD|Nilai perusahaan marang pendapatan CODX|Multiplikator nilai perusahaan marang pendapatan heartsciences.com HSCS|Rasio nilai perusahaan marang pendapatan Biomerica Inc. (BMRA)|Rasio total nilai perusahaan marang pendapatan Cardio Diagnostics Holdings|Multiplikator EV/Sales ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Multiplikator nilai perusahaan marang pendapatan|bluejaydx.com - Multiplikator EV/Sales|Aspira Women's Health - Koefisien nilai perusahaan marang pendapatan|AXDX (Accelerate Diagnostics) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan CENTOGENE, N.V.|Rasio nilai perusahaan marang pendapatan enzo.com|Multiplikator EV/Sales Fresh2 Group Limited|Multiplikator EV/Sales GENE|23andMe Holding Co. - Rasio nilai perusahaan marang pendapatan|Psychemedics Inc - Nilai perusahaan marang pendapatan